BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 19616358)

  • 1. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
    Rath W
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
    Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
    BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbetocin for preventing postpartum haemorrhage.
    Su LL; Chong YS; Samuel M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbetocin for preventing postpartum haemorrhage.
    Su LL; Chong YS; Samuel M
    Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
    Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
    J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
    Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
    BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbetocin versus syntometrine in the management of third stage of labor following vaginal delivery.
    Askar AA; Ismail MT; El-Ezz AA; Rabie NH
    Arch Gynecol Obstet; 2011 Dec; 284(6):1359-65. PubMed ID: 21336835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin agonists for preventing postpartum haemorrhage.
    Su LL; Chong YS; Samuel M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
    Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery.
    Nirmala K; Zainuddin AA; Ghani NA; Zulkifli S; Jamil MA
    J Obstet Gynaecol Res; 2009 Feb; 35(1):48-54. PubMed ID: 19215547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
    Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular oxytocin versus Syntometrine
    van der Nelson H; O'Brien S; Burnard S; Mayer M; Alvarez M; Knowlden J; Winter C; Dailami N; Marques E; Burden C; Siassakos D; Draycott T
    BJOG; 2021 Jun; 128(7):1236-1246. PubMed ID: 33300296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage.
    De Bonis M; Torricelli M; Leoni L; Berti P; Ciani V; Puzzutiello R; Severi FM; Petraglia F
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):732-5. PubMed ID: 21761999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of carbetocin and oxytocin infusions in reducing the requirement for additional uterotonics or procedures in women at increased risk of postpartum haemorrhage after Caesarean section.
    Tse KY; Yu FNY; Leung KY
    Hong Kong Med J; 2020 Oct; 26(5):382-389. PubMed ID: 33028723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
    Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on the use of uterotonic agents].
    Manrique Muñoz S; Munar Bauzà F; Francés González S; Suescun López MC; Montferrer Estruch N; Fernández López de Hierro C
    Rev Esp Anestesiol Reanim; 2012 Feb; 59(2):91-7. PubMed ID: 22480555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.